Cargando…

Inverse baseline expression pattern of the NEP/neuropeptides and NFκB/proteasome pathways in androgen-dependent and androgen-independent prostate cancer cells

BACKGROUND: Castration-resistance in prostate cancer (PC) is a critical event hallmarking a switch to a more aggressive phenotype. Neuroendocrine differentiation and upregulation of NFκB transcriptional activity are two mechanisms that have been independently linked to this process. METHODS: We inve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patrikidou, Anna, Vlachostergios, Panagiotis J, Voutsadakis, Ioannis A, Hatzidaki, Eleana, Valeri, Rosalia-Maria, Destouni, Chariklia, Apostolou, Effie, Daliani, Danai, Papandreou, Christos N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121665/ https://www.ncbi.nlm.nih.gov/pubmed/21569620 http://dx.doi.org/10.1186/1475-2867-11-13

Ejemplares similares

Neuropeptide-inducible upregulation of proteasome activity precedes nuclear factor kappa B activation in androgen-independent prostate cancer cells
por: Patrikidou, Anna, et al.
Publicado: (2012)

The ubiquitin-proteasome system in cancer, a major player in DNA repair. Part 2: transcriptional regulation
por: Vlachostergios, Panagiotis J, et al.
Publicado: (2009)

The ubiquitin-proteasome system in cancer, a major player in DNA repair. Part 1: post-translational regulation
por: Vlachostergios, Panagiotis J, et al.
Publicado: (2009)

Expression of Neutral Endopeptidase, Endothelin-1, and Nuclear Factor Kappa B in Prostate Cancer: Interrelations and Associations with Prostate-Specific Antigen Recurrence after Radical Prostatectomy
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2012)

The ubiquitin-proteasome system in glioma cell cycle control
por: Vlachostergios, Panagiotis J, et al.
Publicado: (2012)

Basic Concepts in Metastatic Cardiac Disease
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2012)

Androgen receptor signaling is required for androgen-sensitive human prostate cancer cell proliferation and survival
por: Yang, Qing, et al.
Publicado: (2005)

Erratum to: Bortezomib represses HIF-1α protein expression and nuclear accumulation by inhibiting both PI3K/Akt/TOR and MAPK pathways in prostate cancer cells
por: Befani, C. D., et al.
Publicado: (2013)

Lack of prognostic significance of p16 and p27 after radical prostatectomy in hormone-naïve prostate cancer
por: Vlachostergios, Panagiotis J, et al.
Publicado: (2012)

Hyposecretion of the adrenal androgen dehydroepiandrosterone sulfate and its relation to clinical variables in inflammatory arthritis
por: Dessein, Patrick H, et al.
Publicado: (2001)

Orbital Metastasis of Breast Carcinoma
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2009)

Degradation and beyond: Control of androgen receptor activity by the proteasome system
por: Jaworski, Tomasz
Publicado: (2006)

Inhibition of androgen-independent prostate cancer cell growth is enhanced by combination therapy targeting Hedgehog and ErbB signalling
por: Shaw, Greg, et al.
Publicado: (2008)

TWIST1, A novel androgen-regulated gene, is a target for NKX3-1 in prostate cancer cells
por: Eide, Turid, et al.
Publicado: (2013)

Cancer Comprehensive Analysis in Gastric Carcinoma: Benefits and New Perspectives
por: Pisanidou, Vasiliki, et al.
Publicado: (2021)

Down-regulation of DcR2 sensitizes androgen-dependent prostate cancer LNCaP cells to TRAIL-induced apoptosis
por: Vindrieux, David, et al.
Publicado: (2011)

LSD1 inhibition attenuates androgen receptor V7 splice variant activation in castration resistant prostate cancer models
por: Regufe da Mota, Sergio, et al.
Publicado: (2018)

Androgens and Androgen Receptor Actions on Bone Health and Disease: From Androgen Deficiency to Androgen Therapy
por: Chen, Jia-Feng, et al.
Publicado: (2019)

INTS6/DICE1 inhibits growth of human androgen-independent prostate cancer cells by altering the cell cycle profile and Wnt signaling
por: Filleur, Stephanie, et al.
Publicado: (2009)

AFP-producing hepatoid adenocarcinoma of the stomach: a case report
por: Vlachostergios, Panagiotis J, et al.
Publicado: (2009)

Androgen regulation of the androgen receptor coregulators
por: Urbanucci, Alfonso, et al.
Publicado: (2008)

Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
por: Chen, Mengqian, et al.
Publicado: (2010)

Selective androgen receptor modulators: the future of androgen therapy?
por: Christiansen, Andrew R., et al.
Publicado: (2020)

The Role of Androgens and Androgen Receptor in Human Bladder Cancer
por: Martínez-Rojo, Elizabeth, et al.
Publicado: (2021)

Should androgen deprivation therapy and other systemic treatments be used in men with prostate cancer and a rising PSA post-local treatments?
por: Patrikidou, Anna, et al.
Publicado: (2021)

Androgens Upregulate Cdc25C Protein by Inhibiting Its Proteasomal and Lysosomal Degradation Pathways
por: Chou, Yu-Wei, et al.
Publicado: (2013)

Androgen and Anaplasia
por: Huggins, Charles
Publicado: (1947)

Androgens and the breast
por: Dimitrakakis, Constantine, et al.
Publicado: (2009)

Androgen Receptor in Laryngeal Carcinoma: Could There Be an Androgen-Refractory Tumor?
por: Goulioumis, Anastasios K., et al.
Publicado: (2011)

The role of androgens and polymorphisms in the androgen receptor in the epidemiology of breast cancer
por: Lillie, Elizabeth O, et al.
Publicado: (2003)

Biological and Clinical Significance of Androgens and Androgen Receptor in Prostate Cancer
por: Koochekpour, Shahriar
Publicado: (2014)

In Vitro Androgen Bioassays as a Detection Method for Designer Androgens
por: Cooper, Elliot R., et al.
Publicado: (2013)

The Androgen Hormone-Induced Increase in Androgen Receptor Protein Expression Is Caused by the Autoinduction of the Androgen Receptor Translational Activity
por: Siciliano, Tiziana, et al.
Publicado: (2022)

Proteasome regulators in pancreatic cancer
por: Murugan, Nirosha J, et al.
Publicado: (2022)

Neuropeptide-induced modulation of carcinogenesis in a metastatic breast cancer cell line (MDA-MB-231(LUC+))
por: Gutierrez, Silvia, et al.
Publicado: (2018)

Enhanced killing of androgen-independent prostate cancer cells using inositol hexakisphosphate in combination with proteasome inhibitors
por: Diallo, J-S, et al.
Publicado: (2008)

Autophagic and Proteasomal Mediated Removal of Mutant Androgen Receptor in Muscle Models of Spinal and Bulbar Muscular Atrophy
por: Cicardi, Maria Elena, et al.
Publicado: (2019)

Proteasome-Mediated Regulation of GATA2 Expression and Androgen Receptor Transcription in Benign Prostate Epithelial Cells
por: Azeem, Waqas, et al.
Publicado: (2022)

Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer
por: Chuu, Chih-Pin, et al.
Publicado: (2011)

Mutational Analysis of Androgen Receptor Gene in Two Families with Androgen Insensitivity
por: Akella, Radha Ramadevi
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ovkmuk1ukbhkdq1u9prebjvjve